Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk inhibitors

4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk inhibitors

US Patent 9290504 · Granted Mar 22, 2016

Estimated economic value: $71,894,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2025
(5,6-dihydro)pyrimido[4,5-e]indolizines2024
Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]2023
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2023
Processed edible product comprising a polyelectrolyte complex and an antimicrobi2023
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor2023
(5,6-dihydro)pyrimido[4,5-E]indolizines2022
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor2021
Imidazopyrazine inhibitors of Bruton's tyrosine kinase2021
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia 2021
Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]2021
3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygen2021